Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care

Table 4 Time to death from all cause and time to cardiovascular (CV) death: Cox proportional hazard models (n = 5596)

	Time to CV death
	Crude HR (95% CI)	Adjusted HR (95% CI)*
Age	1.087 (1.076;1.099)	1.069 (1.057;1.082)
Male gender	0.785 (0.669;0.921)	1.010 (0.857;1.190)
Comorbidity index	1.315 (1.271;1.362)	1.266 (1.222;1.312)
Revascularization (PTCA or CABG)	0.232 (0.165;0.324)	0.368 (0.261;0.518)
Number of classes of medication	0.749 (0.696;0.806)	0.853 (0.790;0.920)

ISSN: 1471-2261